Columbia University — New York, New York

Public research footprint of Columbia University, compiled from the ClinicalTrials.gov public registry.

4,377

Registered studies

1,243

Active

653

Recruiting now

2,393

Completed

598

Stopped or withdrawn

Most-studied conditions

Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Metastatic Bladder Large Cell Neuroendocrine Carcinoma · Metastatic Malignant Solid Neoplasm · Ann Arbor Stage IV Lymphocyte-Depleted Classic Hodgkin Lymphoma

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT07015983 — A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in… (Active Not Recruiting)
NCT06850038 — A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Columbia University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.